MD
Yakir Rottenberg
Senior expert of the Oncology Department of the Hadassah University Hospital.
Areas of Expertise and Treatment
Oncology
- lung cancer
- kidney cancer
- bladder cancer
Other areas of specialization
- Geriatric oncology
- Palliative cancer therapy
Holds a license for prescribing medical cannabis issued by the Israeli Ministry of Health
Inventions and patents
- The doctor is widely known as the inventor of the CureSign© device used to monitor the patient's response to cancer therapy.
- The author of several patents in narcotic substance use for the rehabilitation of patients with various forms of cancer.
Education
- 2003 - Graduated from the Faculty of Medicine of the Hebrew University of Jerusalem (Israel).
- 2009 - Obtained a second academic degree in social hygiene and healthcare organization from the Hebrew University of Jerusalem.
- 2014 - Completed a course on biomedical innovations at the Hebrew University of Jerusalem.
- 2019 - Completed a special course on the use of biotechnologies in personalized medicine and digital means and narcotic medicines at the Hebrew University of Jerusalem.
Awards and Honors
- 2019 - the prestigious grant of the National Cancer Association for research in nasal chemotherapy of cerebrovascular diseases.
Clinical Experience
- 2004–2009 - Specialization in oncology at the Hadassah University Hospital (Jerusalem, Israel).
- 2009–2012 - Specialization in geriatric rehabilitation at the Hadassah University Hospital.
Professional Memberships
- The Israeli Association of Oncology
- The International Association of Oncology (IAO)
Years of Experience: 16
Areas of Expertise and Treatment
Oncology
- lung cancer
- kidney cancer
- bladder cancer
Other areas of specialization
- Geriatric oncology
- Palliative cancer therapy
Holds a license for prescribing medical cannabis issued by the Israeli Ministry of Health
Inventions and patents
- The doctor is widely known as the inventor of the CureSign© device used to monitor the patient's response to cancer therapy.
- The author of several patents in narcotic substance use for the rehabilitation of patients with various forms of cancer.
Education
- 2003 - Graduated from the Faculty of Medicine of the Hebrew University of Jerusalem (Israel).
- 2009 - Obtained a second academic degree in social hygiene and healthcare organization from the Hebrew University of Jerusalem.
- 2014 - Completed a course on biomedical innovations at the Hebrew University of Jerusalem.
- 2019 - Completed a special course on the use of biotechnologies in personalized medicine and digital means and narcotic medicines at the Hebrew University of Jerusalem.
Awards and Honors
- 2019 - the prestigious grant of the National Cancer Association for research in nasal chemotherapy of cerebrovascular diseases.
Clinical Experience
- 2004–2009 - Specialization in oncology at the Hadassah University Hospital (Jerusalem, Israel).
- 2009–2012 - Specialization in geriatric rehabilitation at the Hadassah University Hospital.
Professional Memberships
- The Israeli Association of Oncology
- The International Association of Oncology (IAO)
- Opening Hours
WE ARE HERE FOR YOU 24 hours DAILY.
- Opening Hours